Remdesivir Approval Status FDA Approved: No Generic name: remdesivir Company: Gilead Sciences, Inc. Treatment for: COVID-19 Remdesivir is an investigational antiviral compound undergoing clinical trials in China, the United States, and the United Kingdom as a potential treatment for COVID-19. Remdesivir is not yet licensed or approved anywhere globally and has not been demonstrated to be safe or effective for any use.…

Read more →